Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Standard Dose
325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is listed in Drugs@FDA under application 088825 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL; CAFFEINE Form and strength CAPSULE;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GILBERT LABS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is listed in Drugs@FDA under application 088825 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL; CAFFEINE Form and strength CAPSULE;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GILBERT LABS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.